Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LLME-Treated Non-Myeloablative Allogeneic HSCT for Hematological Malignancies
NCT00429416Phase 2Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Mar 2004
- Primary completion
- Dec 2008
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of l-leucyl-l-leucine methyl ester in hematologic malignancy, sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Mar 2004; status: completed.
02
Drugs
l-leucyl-l-leucine methyl ester
03
Conditions
hematologic malignancy
Beyond the preview
Go deeper on NCT00429416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00429416.